The objective of the present study is to investigate the role of heat shock proteins (Hsps) in preimplantation embryonic development and uterine receptivity during lipopolysaccharide (LPS)-induced pregnancy loss. Mice were treated with PBS or LPS on Day 0.5 of pregnancy, and preimplantation embryos and uterus were collected on Days 1.5-4.42 of pregnancy. The individual preimplantation embryos were assessed for their morphologic appearance and DNA damage during the preimplantation period of pregnancy. The expression of Hsp90, Hsp70, Hsp60, and Hsp25 was determined in preimplantation embryos and uterus by RT-PCR. Comet studies showed that LPS treatment significantly increased the percentage of abnormal embryos and DNA damage in the embryos. The expression of Hsp90, Hsp70, and Hsp60 was significantly lower in preimplantation embryos recovered from LPS-treated mice when compared to their respective controls. The expression of Hsp90, Hsp70, Hsp60, and Hsp25 was altered in uterus of LPS-treated mice when compared to their respective controls. Immunohistochemistry studies showed that at the time of implantation (i.e., Day 4.42), levels of Hsp90 and Hsp60 were decreased in stromal cells of LPS-treated uterus when compared to their respective controls. Hsp25 was highly expressed in the endometrium and stromal cells of LPS-treated uterus. Our results clearly showed that lowering of embryonic expression of Hsps induces DNA damage, which leads to degeneration and degradation of preimplantation embryos, and altered uterine expression of Hsps may not prepare the uterus for implantation. This may ultimately lead to implantation failure in mouse.
INTRODUCTION
Lipopolysaccharide (LPS) motifs are found in the majority of gram-negative bacteria [1] . By using Toll-like receptor (TLR) 4, LPS induces the production of various proinflammatory cytokines from different cell lineages and animals [2] . This activation of TLR4 by the exposure of LPS in various animals (including human) is one of the major causes of blastocyst implantation failure [3] [4] [5] [6] [7] [8] [9] [10] and preterm labor [11, 12] . Previously it has been shown that bacterial infection is strongly associated with pregnancy disorders such as implantation failure, abortion, preterm labor, intrauterine growth retardation, and preeclampsia [13, 14] . Despite multiple strategies attempting to inhibit preterm delivery, the rate of preterm delivery has increased from 10% to 12.7% of all pregnancies [15] . At least 40% of pregnancy disorders are associated with bacterial infections. LPS also potentiates the release of reactive oxygen intermediates and lytic enzymes, resulting in septic shock [16] . As previously reported, the increase in body temperature induces physiological and metabolic adaptations by inducing up-regulation of a polypeptide family designated as heat shock proteins (Hsps) [17] .
Hsps protect cells against various stresses such as endotoxin and reactive oxygen species [18, 19] . Some of these Hsps work as molecular chaperones and play a significant role in the folding and translocation of polypeptides across membranes in unstressed cellular systems [20] [21] [22] . This protective function of Hsps reflects their ability to overwhelm several forms of cell death, including apoptosis [23] [24] [25] . The Hsp90, Hsp70, Hsp60, and Hsp27 subfamilies have been involved in the protection against apoptosis induced by a variety of stimuli, such as chemotherapeutically induced DNA damage, UV radiation [26, 27] , death receptor ligation [28] , heat shock [29, 30] , reactive oxygen species, etc. LPS is a well reported inducer of endotoxin (septicemic) shock in pregnant females, and disrupts the normal coordination required between embryonic and uterine development for the success of pregnancy [4, 7] . Bacterial LPS induces the production of several Hsps in vivo [31] . Hsps are expressed in the cells as a consequence of heat shock, lead acetate, and LPS treatment in both in vivo and in vitro [32] .
Our previous studies suggest that LPS inhibits the implantation of blastocysts in mouse by modulating the expression of different cytokines like tumor necrosis factor a [6] and interleukin 1 [5, 7] and growth factors like CSF-1 [8] .
We have also provided evidence that the delivery of LPS to pregnant females at coitus causes embryonic cell death and induces DNA damage in nonsuperovulated embryos and uterine cells [9] and alteration of steroid hormone and gonadotropins during the preimplantation period of pregnancy [10, 33] . It has been established that gram-negative bacteria or its component triggers implantation failure in various animal models, and many attempts have been made to clarify this mechanism [13, 34] .
We have demonstrated previously that LPS induces septic shock [35, 36] and DNA damage in the preimplantation embryos and uterus [9] . We hypothesize that LPS drives these effects via alternation in the expression of implantation-specific Hsps (Hsp90, Hsp70, Hsp60, and Hsp25) in the embryonic and uterine cells. In the present study, a mouse model of LPSinduced implantation failure [5] is used to study the role of Hsps (Hsp90, Hsp70, Hsp60, and Hsp25) in embryo development and uterine receptivity during the preimplantation period of pregnancy.
MATERIALS AND METHODS

Animal Model
Park strain mice (6-8 wk, 20-21 g) were maintained in the Biological Resource Facility of the Biochemistry Department, Jiwaji University, Gwalior, India. All animals were treated in accordance with institutional ethics committee guidelines for the care and use of animals in research. Females in proestrus were selected by measuring vaginal electrical resistance [3] and impregnated naturally by males. Mating was confirmed by the presence of vaginal plug and the morning of plugging considered as Day 0.5 of pregnancy.
Treatment
Two hundred fifty micrograms per kilogram of body weight, i.e., 5 lg/ animal, LPS (Salmonella enterica serotype Minnesota Re 595; Sigma) was injected i.p. in pregnant animals on Day 0.5 of pregnancy [5] . Salmonella enterica is one of the common sources of endotoxin for women experiencing gram-negative sepsis and implantation failure [37] . The control animals were injected with sterile PBS in the same manner.
Recovery and Assessment of Preimplantation Embryos
Park strain mice were superovulated and mated as described earlier [5, 8] . The preimplantation embryos were recovered from the female reproductive tract in sterile PBS on Days 1.5, 2.5, 3.5, and 4.375 of the preimplantation period of pregnancy. The morphology of the recovered embryos from control and LPS-treated animals was examined under an inverted phase-contrast microscope (Leica DMIL; Leica Microsystems) using a 1003 objective and photographed. The same embryos were used for further analysis. Six animals were used for each group.
Comet Assay
Detection of DNA damage in individual superovulated embryos recovered from the control and LPS-treated animals at different stages of the preimplantation period of pregnancy was carried out as previously described by Jaiswal et al. [9] in nonsuperovulated embryos. Thirty superovulated embryos in each experimental group were transferred to a 100-ll drop of 1% low-melting-temperature agarose in PBS at 378C. The agarose drop was placed on a 35-mm plastic Petri dish. The embryos were gently mixed with the agarose and captured in a total volume of 30 ll with a micropipette using a stereo dissecting microscope. The embryos were quickly placed as a drop on a frosted super deluxe micro glass slide (Blue Star) that was initially coated with 1% high-melting-temperature agarose. The slides were placed on ice for 5 min to solidify the agarose. The embryos were incubated in lysing buffer (1.25 M NaCl, 100 mM Tris-HCl, pH 10, 50 mM EDTA, 1% Triton X-100, and 10% dimethyl sulfoxide [DMSO] ) for 3 h at ambient temperature to denature DNA (and dissociate DNA-associated proteins) and to degrade RNA. The slides were placed on a horizontal gel electrophoresis unit (Pharmacia) filled with fresh electrophoresis buffer (10 N NaOH, 200 mM EDTA, 0.0004% DMSO, pH 13.0) to a level of 25 mm above the slides. The electrophoresis was carried out at 25 V for 25 min at 48C using an electrophoresis compact power supply (BioRad). After electrophoresis, the slides were neutralized by adding neutralization buffer (0.4 M Tris-HCl, pH 8.0) drop-wise for 5 min at 48C. The DNA was detected by adding a 50-ll drop of ethidium bromide (1 lg/ml) to the slides for 10 min. The stained slides were washed with chilled double-distilled water and observed under a fluorescence microscope (Leica DM4000B; Leica Microsystems) with an excitation filter of 515-560 nm and a barrier filter of 590 nm using 103 objectives. Photographs of the individual embryos were taken by a Leica Digital DFC 320R-II camera (Leica Microsystems). All steps were conducted in the dark to prevent additional DNA damage. Comet tail length and percentage fragmented DNA in tail were measured with an Image Analysis System (Leica Qwin; Leica Microsystems) and Comet score software version 1.5 (TriTek Corporation).
Gene Expression of Heat Shock Proteins
To determine the gene expression of Hsps (Hsp90, Hsp70, Hsp60, and Hsp25) in preimplantation embryos (n ¼ 6 in each group), animals were superovulated with standard protocol [5, 8] , and to determine expression in uterus (n ¼ 5 in each group) unsuperovulated animals were used. Animals received either PBS or LPS on Day 0.5 of pregnancy and were killed on Days 1.5, 2.5, 3.5, 4.0, 4.125, 4.33, and 4.42 of pregnancy, and preimplantation embryos or uteruses were collected and processed for RNA extraction immediately.
RNA Extraction
Embryos. A total of 100 morphologically normal embryos were collected from control and LPS-treated animals on Days 1.5 (n ¼ 3 for both groups), 2.5 (n ¼ 3 for control; n ¼ 4-5 for LPS-treated), 3.5 (n ¼ 3 for control; n ¼ 4-5 for LPS-treated), 4.0 (n ¼ 3 for control; n ¼ 5 for LPS-treated) and 4.125 (n ¼ 3 for control; n ¼ 6-7 for LPS-treated). On later days of pregnancy, i.e., Day 4.33 and 4.42, a total of 60-70 morphologically normal embryos were collected from control and LPS-treated groups (n ¼ 3 for control; n ¼ 14-16 for LPStreated). Embryos were washed, resuspended in 50 ll sterile PBS, and used for extraction of total cellular RNA using High Pure RNA Isolation Kit (Roche Diagnostics GmbH) according to the manufacturer's instructions. Final washes of embryos were collected and used as a negative control. RNA was eluted in 60 ll of elution buffer and RNA equivalent to five embryos was used for each RT-PCR reaction.
Uterus. Total cellular RNA was purified from tissue specimens after homogenization in Trizol reagent (Gibco BRL) according to the manufacturer's instructions. Quantity and integrity of RNA were confirmed by the ratio at 260:280 nm and electrophoresis on 1.5% native agarose gel to visualize 18S and 28S ribosomal RNA subunits.
Primer Designing for RT-PCR
The RT-PCR primers for Hsp90, Hsp70, Hsp60, Hsp25, and b-actin were designed by using Primer Express software (Applied Biosystems). DNA and mRNA sequences of genes were taken from MGI 3.54 (The Jackson Laboratory; http://www.informatics.jax.org). The approximate positions of primer pairs were checked by Spidey software (National Library of Medicine). The oligonucleotide primers were designed to cross intron and exon boundaries for discrimination of the amplified products from genomic DNA and cDNA and synthesized by Sigma Genosys (Sigma Aldrich Chemicals Pvt. Ltd.). Sequences of primers, annealing temperatures, and amplicon lengths are shown in Table 1 .
RT-PCR
Expression of Hsp90, Hsp70, Hsp60, Hsp25, and b-actin genes was analyzed by RT-PCR (with outer primer) followed by nested PCR (with inner primer) in embryos and by RT-PCR (with only inner primer) in the uterine tissues. The RT followed by PCR was carried out using the Titan One Tube RT-PCR System (Roche Diagnostics GmbH) according to manufacturer's instructions. Each RT-PCR reaction was performed in 50 ll mixture containing 2 lg RNA for tissues and for embryos RNA equivalent to five embryos with 0.4 lM of each primer, 0.2 lM dNTP mix, 5 mM dithiothreitol, 10 U RNase inhibitor, and 1 U enzyme mix. Cycling conditions were followed according to manufacturer's instructions with annealing temperatures mentioned in Table 1 by using a gradient in a thermocycler (Bio-Rad Laboratories) and 35 cycles for each gene.
Nested PCR
The product of first-round gene-specific RT-PCR was used to carry out nested PCR for the preimplantation embryos. Nested PCR reaction was performed in 50 ll reaction mixture containing 0.2 ll of the first-round PCR product, 0.4 lM each primer, 0.2 lM dNTP mix, and 0.5 U Taq DNA Polymerase (MBI Fermentas). Cycling conditions were as follows: initial denaturation at 948C, 2 min; denaturation at 948C, 10 sec; annealing temperature as mentioned in Table 1 , 30 sec; elongation 728C, 45 sec; final elongation at 728C, 7 min, using a gradient in a thermocycler and 25 cycles for each gene.
After amplification, PCR products were size fractionated by agarose gel electrophoresis (1.5%). Fifteen microliters of amplified product using inner JAISWAL ET AL.
primers from embryos, ovaries, and uterus was loaded on the agarose gel, visualized by ethidium bromide staining under a UV transilluminator (Bio-Rad Laboratories), and photographed. The semiquantitative analysis of PCR products was done by densitometric scanning using AlphaEaseFC software, version 3.0 (Alpha Innotech Corporation). The intensity of bands observed for different genes in both groups was normalized with the intensity of b-actin bands observed under the same experimental conditions. The identities of amplified PCR products for all cDNAs were verified by sequencing.
Immunohistochemistry
The uterine horns were collected from PBS-and LPS-treated groups on Day 4.42 of pregnancy. Tissues were fixed in 10% neutral-buffered formalin at 48C overnight, rinsed three times in PBS for 5 min with rocking, and infused with 30% sucrose solution at 48C overnight or until the tissue sank. The tissues were snap frozen in OCT (Tissue-Tek) by liquid nitrogen. Frozen tissue was stored at À808C until further use. Frozen 5-lm sections from frozen tissues were mounted onto saline-coated glass slides (Dako) and stored at À808C until used. The Dako EnVisionþ System-HRP (DAB) (Dako) was used to stain the frozen sections according to the manufacturer's instructions with slight modifications. The sections were heated in the microwave in sodium citrate buffer (pH¼6) for antigen retrieval.
For protein detection, sections were incubated with 10 lg/ml of anti-Hsp90 mouse monoclonal antibody and 1:100 dilutions of anti-Hsp60 rabbit polyclonal and anti-Hsp25 mouse monoclonal antibodies (Abcam) in 1% bovine serum albumin-PBS for 2 h at room temperature. After washing, sections were incubated with secondary antibody EnVisionþ System-HRP-labeled polymer anti-mouse or anti-rabbit. The chromogen 3,3 0 diaminobenzidine was used as substrate for the EnVisionþ System-HRP according to the manufacturer's instructions. The sections were counterstained with Meyer hematoxylin and mounted in Faramount aqueous mounting medium (both from Dako). The immune staining was evaluated in images generated by light microscopy (Carl Zeiss) and a high-resolution camera (Canon G10).
Statistical Analysis
The results of each experiment were analyzed by using one-way ANOVA with Duncan multiple-range test for comparison of the significance level (P) between control and treated values. A P value ,0.05 was considered as significant difference between the values compared.
RESULTS
Effect of LPS on the Development of Preimplantation-Stage Embryos Collected from Superovulated Pregnant Animals
Preimplantation-stage embryos were recovered from the reproductive tracts of superovulated control and LPS-treated pregnant animals during different stages of the preimplantation period of pregnancy (i.e., from Day 1.5 to 4.375) to assess the effect of LPS on preimplantation embryonic development in superovulated pregnant animals. Control and LPS-treated pregnant animals were observed for health status and body weight, and there was no difference between the two groups. There was no significant difference in the number of abnormal embryos recovered from control (6.4% 6 0.5%) and LPStreated (8.1% 6 0.4%) animals on Day 1.5 of pregnancy (Fig  1, A, E, and I ). Morphologic analysis of preimplantation-stage embryos on Days 2.5, 3.5, and 4.375 showed that embryos were developmentally arrested, degenerated, and fragmented in the LPS-treated animals when compared to the respective controls (Fig. 1, B-D and F-H) . Moreover, the percentages of developmentally abnormal embryos were significantly higher in the LPS-treated animals (Day 2.5, 38.0% 6 0.3%; Day 3.5, 39.5% 6 2.0%; Day 4.375, 88.9% 6 1.7%) when compared to the control (Day 2.5, 9.8% 6 0.7%; Day 3.5, 9.5% 6 0.6%; Day 4.375, 19.5% 6 1.2%) (Fig. 1I) .
Comet assay of embryos showed that both percentages of embryos having a tail and mean comet tail length of embryos were significantly higher in the LPS-treated animals as compared to the control animals during different days of the preimplantation period of pregnancy (Fig. 2, A-F) . This extensive DNA damage in the embryos (which is shown by the presence of a comet tail) is directly correlated with the percentage of abnormal embryos. The percentages of abnormal embryos were plotted against the percentage of embryos having a tail or mean comet tail length. When a linear regression analysis was performed, R 2 values of 0.9244 (percentage of abnormal embryos vs. percentage of embryos having tail) and 0.9014 (percentage of abnormal embryos vs. comet mean tail length) were obtained (Fig. 2, G and H) .
Effect of LPS on Gene Expression of Heat Shock Protein in Embryos Collected at Different Stages of the Preimplantation Period of Pregnancy
We observed that significant degeneration of superovulated embryos in LPS-treated animals was due to extensive DNA damage. Previously, we have shown that the increase in degeneration of nonsuperovulated embryos was correlated with the increase in number of embryos having tail and mean comet 
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tail length [9] . In this study, we showed that the observed degeneration and extensive DNA damage in the preimplantation-stage embryos is a reflective event of altered expression of Hsps (Hsp90, Hsp70, Hsp60, and Hsp25). Hsp90, Hsp70, Hsp60, and Hsp25. The gene expression of Hsps in the preimplantation-stage embryos was analyzed by RT-PCR followed by nested PCR. RT-PCR analysis showed that Hsp90, Hsp70, Hsp60, and Hsp25 gene expression began with the first zygotic cleavage. The mRNA expression of Hsp90 was lower on Day 1.5 and significantly lower on Days 2.5-4.42 (P , 0.05) in embryos collected from LPS-treated animals when compared to the respective controls (Fig. 3, A , B, and G). Hsp70 gene expression was highest in the two-cell embryos (Day 1.5) recovered from the control animals. However, in the LPS-treated animals, its expression was significantly lower in the two-cell embryos. On Days 2.5 and 3.5, Hsp70 was slightly lower in the LPS-treated embryos when compared to their respective controls. Thereafter, Hsp70 gene expression was significantly lower (P , 0.05) in the embryos collected near the window of the implantation period (Days 4-4.42) from the LPS-treated animals when compared to their respective controls (Fig. 3, C, D, and H) . Hsp60 mRNA expression was significantly lower (P , 0.05) in the embryos recovered from LPS-treated animals on Days 1.5-3.5 of pregnancy (i.e., from two-cell to morula stage) when compared to their respective controls. However, a slightly decreased level of Hsp60 mRNA was maintained in the LPS-treated preimplantation-stage embryos until Day 4.33 of pregnancy. Thereafter, a significant decrease in expression was observed on Day 4.42 of pregnancy when compared to the respective controls (Fig. 4, A, B , and E).
No significant difference was observed in expression of Hsp25 in preimplantation embryos collected from control and LPS-treated animals on any day of pregnancy except Day 3.5 (Fig. 4, C, D, and F) . A uniform expression of b-actin gene was observed in embryos collected from control and LPS-treated animals during different stages of the preimplantation period of pregnancy (Fig. 3, E and F) . JAISWAL ET AL. detected in uterus on Day 2.5 of pregnancy and the same level was maintained until Day 3.5 of pregnancy. An increase in the expression of Hsp90 mRNA was observed in uterus on Day 4.0 of pregnancy and was maintained until Day 4.33 of pregnancy. However, its level was slightly decreased in uterus collected from control animals on Day 4.42 of pregnancy (Fig. 5, A and  G) . In contrast to control, the highest level of expression of Hsp90 was observed in uterus recovered from LPS-treated animals on Day 1.5 of pregnancy. Thereafter, its level of expression was gradually decreased in uterus as the day of pregnancy progressed in LPS-treated animals. The mRNA expression of Hsp90 was significantly higher in uterus recovered from LPS-treated animals on Days 1.5, 2.5, and 3.5 of pregnancy when compared to their respective controls. Thereafter, its level was reduced in the uterus from Day 4.0 to 4.42 of pregnancy in LPS-treated animals when compared to their respective controls. Moreover, no Hsp90 mRNA was detected in uterus recovered from LPS-treated animals on Day 4.42 of pregnancy (Fig. 5, B and G) .
Effect of LPS on Heat Shock Proteins in the Uterus
LPS treatment decreased the expression of Hsp90 protein in the stromal cells (Fig. 7B) of uterus, although endometrium, glandular epithelium, and myometrium (Fig. 7D ) remained unchanged on Day 4.42 of pregnancy in comparison to control (Fig. 7, A and C) , as shown by immunohistochemical analysis.
Hsp70. The highest level of expression of Hsp70 was observed in uterus recovered from control animals on Day 1.5 of pregnancy. A gradual fall in the positive mRNA signal was observed in control uterus until Day 3.5 of pregnancy. On Day 4 of pregnancy, the expression of Hsp70 was increased in uterus, and the same higher level was maintained until the day of implantation (Fig. 5, C and H ). However, a lower level of expression of Hsp70 was found in uterus recovered from LPStreated animals on Day 1.5 of pregnancy when compared to their respective controls. This level of expression of Hsp70 was maintained in uterus until Day 3.5 of pregnancy, but it was significantly higher than that of the respective controls. Thereafter, its level remained the same in both groups (Fig.  5, D and H) . 
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Hsp60. The expression of Hsp60 mRNA was significantly higher in uterus collected from control animals from Days 1.5 and 2.5 of pregnancy when compared to the LPS-treated animals. Hsp60 expression went down on Day 3.5 of pregnancy, followed by a gradual increase from Day 4.0 until the time of implantation (i.e., on Day 4.42 of pregnancy) in the uterus recovered from the control animals (Fig. 6, A and E) . Its level and pattern of expression were observed to be almost similar in both control and LPS-treated animals on Days 3.5 and 4.33 of pregnancy. At the time of implantation, i.e., Day 4.42, the expression of Hsp60 was significantly lower in uterus recovered from LPS-treated animals as compared to their respective controls (Fig. 6, B and E) . Immunohistochemistry also showed that at the time of implantation, Hsp60 protein JAISWAL ET AL. level was lowered in the stromal cells of the LPS-treated uterus (Fig. 7, F and H ) when compared to their respective controls (Fig. 7, E and G) . The level and pattern of Hsp60 were altered in uterus in response to LPS, which may impair uterine receptivity and may lead to poor pregnancy outcome in mouse.
Hsp25. Consistent expression of Hsp25 was observed in the uterus recovered from control animals from Day 1.5 to 4.42 of pregnancy (Fig. 6, C and F) . However, the level of expression of Hsp25 was significantly higher in uterus recovered from LPStreated animals during all the time points of the preimplantation period of pregnancy when compared to their respective controls.
Its highest level of expression was detected in uterus recovered from LPS-treated animals on Day 3.5 of pregnancy (Fig. 6, D  and F) . Immunohistochemistry also showed that at the time of implantation, i.e., Day 4.42, Hsp25 protein was highly expressed in the endometrium and stromal cell of the LPS-treated uterus (Fig. 7J) , whereas no positive staining was observed in the endometrium of the control uterus (Fig. 7I) . Hsp25 protein level remained unchanged in glandular epithelium and myometrium of uterus in both groups (Fig. 7, K and L) .
A uniform expression of b-actin was observed in uterus collected from control and LPS-treated animals during different 
stages of the preimplantation period of pregnancy (Fig. 5, E  and F) . The identity of the RT-PCR products for Hsp90, Hsp70, Hsp60, Hsp25, and b-actin was confirmed by their nucleotide sequence analysis.
DISCUSSION
Gram-negative bacterial infections are strongly associated with the various pregnancy disorders [13, 14] . Various gramnegative bacterial infections like S. enterica infection cause systemic infection and enteritis, which not only alters maternal immunity but also is associated with several pregnancy disorders [37] . Previously, we have reported that LPS from S. enterica induces failure of blastocyst implantation due to modulation in the expression of different proinflammatory cytokines in mouse [4-8, 38, 39] . LPS-induced embryo resorption has been correlated with the altered level of several other cytokines, such as interferon c [40] , IL-2 [41] , and IL-6 JAISWAL ET AL. [42] . The expression of some immunosuppressive cytokines, such as TGF-b2 [43] and IL-10 [44] , is also modulated by LPS during pregnancy in mouse.
The proinflammatory cytokines are the mediators of inducing septicemia, and the members of Hsp families are key regulators to prevent septicemic damage in endometrium [45] . Hsps are able to protect the cells from stress and inhibit apoptosis by several mechanisms [23-25, 46, 47] . The expression of all Hsp families has been found in endometrium and in decidual cells of healthy women [48, 49] . The expression of Hsp family members among the first proteins synthesized during mammalian embryonic development underscores their role during early pregnancy [50] . The altered expression of Hsps has also been reported in fallopian tubes of women with ectopic pregnancy [49] . A maximum expression of Hsp27, Hsp60, and HSC70 has been found in the endometrium after ovulation and in the early secretory phase, which is the critical period of endometrial receptivity for an implanting embryo in women [49] . It has been reported that a high level of Hsp modulates the functions of ovarian steroids (estradiol [E 2 ] and progesterone [P 4 ]) in the endometrium [51] . Cumulatively, these findings suggest that Hsps play a distinct role during implantation and decidualization. 
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Our RT-PCR data showed that the gene expression of Hsp90, Hsp70, and Hsp60 was significantly decreased in the different stages of preimplantation embryos recovered from LPS-treated animals. Pandey et al. [52] showed that Hsp90 blocks caspase-3 activation and apoptosis. Hsp90b also blocks the oligomerization of apoptosis-inducing factor 1 (Apaf-1), which prevents inexorable apoptosis. Hsp70 expression begins with the first zygotic cleavage [53, 54] , and it exerts a protective effect against apoptosis for preimplantation embryos [55] . Ravagnan et al. [56] have reported that Hsp70 is a wellknown inhibitor of apoptosis. Cytochrome c triggers the oligomerization of Apaf-1, which in turn recruits procaspase-9 and procaspase-3 into the apoptosome (i.e., caspase activation multiprotein complex). Hsp70 interacts with Apaf-1 and prevents its interaction with procaspase-9. Hsp60 also acts as a potent inhibitor of apoptosis by binding to Bax and Bak proteins in the cytosol of cardiac myocytes [57] [58] [59] . It has been previously reported that the antibodies against Hsp90, Hsp70, and Hsp60 exert a detrimental effect on the development of mouse preimplantation embryos and make them more susceptible to apoptotic cell death, which leads to poor pregnancy outcome [60] . In this study we have shown that LPS-treated preimplantation embryos had extensive DNA damage and significantly lower expression of Hsp90, Hsp70, and Hsp60. This lowered gene expression of Hsps may be a key mediator for the induction of extensive DNA damage in preimplantation embryos, which leads to their degeneration and degradation. This extensive DNA damage in preimplantation embryos is positively correlated with down-regulation of Hsp90, Hsp70, and Hsp60 gene expression in the LPS-treated group.
Hsp90 binds to sex steroid receptors, estrogen receptor (ER), and P 4 receptor (PR). Hsp90 is known to mask the functional domains of sex steroid receptors and keep them in their inactive state [61] . The association of Hsp90 is a principal regulator for the maintenance of the appropriate conformation of steroid receptors, which is required for hormone binding and its activity through their receptor [62] . Therefore, the fluctuation in the expression of Hsp90 expression in the myometrium is parallel with the changes in sex steroid receptor levels. Previously we have demonstrated that in control uterus, ER and PR were undetectable on Day 1.5, appeared on Day 2.5, and were maintained throughout the window of implantation [63] . The gene expression of Hsp90 follows the gene expression patterns of PR and ER in the control uterus. This distinct positive correlation between the gene expression pattern of Hsp90, PR, and ER may be necessary to regulate the normal physiology of the sex steroid receptors for maintenance of uterine receptivity in favor of successful implantation. However, in LPS-treated animals, an inverse pattern of Hsp90 gene expression and decreased level of Hsp90 protein at the time of implantation was observed in the uterus as compared to their respective controls, which may disturb definite coordination between Hsp90 and sex steroid receptors in the uterus. These changes force the uterus into a nonreceptive stage and ultimately lead to implantation failure.
We observed that LPS altered the uterine expression of Hsp70 from Day 1.5 to 3.5 of pregnancy; thereafter, its expression remained the same in the control and LPS-treated groups. Komatsu et al. [64] reported that Hsp70 is inversely regulated to P 4 action in the myometrium. It is well known that P 4 plays a vital role in the proliferation and morphologic and functional differentiation of the myometrium during the preimplantation period of pregnancy. The observed higher Hsp70 gene expression on Day 2.5 and 3.5 of pregnancy in the LPS-treated uterus may inhibit the required proliferation and morphologic and functional differentiation of the myometrium. This may render the uterus nonreceptive to implanting embryos and lead to implantation failure.
Estrogen-regulated Hsp25/27 regulates the molecular and morphogenetic events in the uterus for the success of blastocyst implantation [65] . We observed a constitutive expression of Hsp25 gene in the uterus during the preimplantation period of pregnancy. Transcription of Hsp25/27 gene is regulated by heat shock elements and by estrogen-responsive elements [66] . E 2 stimulates the expression and phosphorylation of Hsp27 in mouse [67] . Estrogen and P 4 priming of the uterus and then a secondary surge of estrogen are essential to trigger several events that allow implantation to begin [68] . It is tempting to speculate that Hsp25/27 may be a factor implicated in embryouterus attachment. Hsp25/27 is also highly expressed in the fallopian tubes [69] , an organ where embryos usually do not attach. In the LPS-treated condition, expression of Hsp25 mRNA transcript in the uterus remains higher throughout the preimplantation period as compared to the control. Previously we have reported a high serum level of E 2 in LPS-treated animals [33] . The observed increased expression of Hsp25 gene in the LPS-treated uterus may be due to the high serum E 2 during the preimplantation period of pregnancy. Immunohistochemistry studies also have confirmed that the Hsp25 was highly expressed in the endometrium and stromal cells of the LPS-treated uterus on Day 4.42 of pregnancy. This higher expression of Hsp25 may disturb the molecular and morphogenetic events necessary for the attachment of embryos in the uterus and contribute to the inhibition of implantation in mouse.
Cumulatively, these results provide two important pieces of evidence related to LPS-induced implantation failure. First, the lowering of embryonic expression of Hsps induces DNA damage, which leads to degeneration and degradation of the preimplantation embryos. Second, the altered uterine expression of Hsps may not prepare the uterus for implantation, which may ultimately lead to early pregnancy loss in mouse.
